Skip to content
healthcare.dev

Orostat 8%

NDC 10129-006, EPINEPHRINE HYDROCHLORIDE, solution, from Gingi-Pak a Division of the Belport.

Product NDC
10129-006
Status
Listed
Labeler
Gingi-Pak a Division of the Belport
Dosage form
SOLUTION
Route
DENTAL, PERIODONTAL, SUBGINGIVAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10129-006 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EPINEPHRINE HYDROCHLORIDE1200 mg/15mL

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Catecholamine [EPC]; Catecholamines [CS]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
10129-006-021012900060215 mL in 1 BOTTLE, GLASS (10129-006-02)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 10129-006 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10129-006 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10129-006. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.